FMC Corporation (NYSE:FMC), a leading global agricultural sciences company, today announced that Isoflex® active, the trade name for bixlozone, has received regulatory approval in the European Union (EU). This approval is a critical milestone in FMC's commercialization process, paving the way for the introduction of formulated products across more than 55 million planted hectares of cereals, corn, oilseed rape and potato in the EU. Product dossiers have been submitted for these crops, and pending regulatory decisions, FMC anticipates launching products powered by Isoflex® active beginning in 2027.  

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.